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Agonist-specific regulation of aryl hydrocarbon receptor target genes in 
a Xenopus laevis cell line
Kay Burrows ‘18, Nathan Huey ‘13, and Wade H. Powell, Ph.D 
Kenyon College Summer Science Scholars 2016 
Abstract	
In vertebrates, the activation of the aryl hydrocarbon receptor 
(AHR) by toxic contaminants such as 2,3,7,8 tetrachlorodibenzo-
p-dioxin (TCDD) induces the Cytochrome P450 1A (CYP1A) 
family of genes . The endogenous AHR agonist 6-formylindolo 
(3,2-b) carbazole (FICZ) also induces CYP1A strongly, but is not 
toxic. In order to discern the underlying mechanism for this 
difference in toxicity, we sought to determine whether FICZ and 
TCDD alter the expression of the same genes outside of the 
CYP1A family. We hypothesized that FICZ and TCDD exposure 
would induce unique sets of gene targets, suggesting selective 
modulation of gene expression as an underlying mechanism for 
toxicity. We treated the Xenopus laevis cell line, XLK-WG with 
TCDD or FICZ concentrations corresponding to the the EC50  for 
CYP1A6 induction. RNAseq analysis of transcribed RNA 
revealed 162 genes that were commonly induced or repressed 
by both agonists, 65 transcripts uniquely altered by TCDD 
treatment, and 235 genes that responded only to FICZ exposure. 
We next sought to verify these results using a second method, 
quantitative RT-PCR (qPCR). Surprisingly, our qPCR results 
contradicted our original RNAseq findings for several target 
genes. While genes induced or repressed by both compounds, 
such as SYNE1 and HAS2.L,  matched their trend in the RNAseq 
data, genes previously exhibiting agonist-dependent expression 
changes, such as NOV.L and TIPARP.L,  responded similarly to 
TCDD or FICZ treatment. In the future, we hope to find the cause 
for this discrepancy in these data, ultimately determining the 
actual prevalence of selective modulation in the AHR pathway. 
Background	
•  TCDD and FICZ induce CYP1A family genes through the 
ligand-activated transcription factor AHR. The genes targeted 
by AHR are crucial in phase 1 and 2 detoxification reactions 
and other important developmental functions.
•  Though both are AHR agonists, TCDD is toxic and FICZ is not.
•  To uncover potential mechanisms for toxicity, we aim to 
determine whether TCDD and FICZ selectively modulate gene 
expression
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Figure 1. Agonist-dependent AHR gene targets.  RNAseq 
analysis of the the transcribed genes extracted from each 
treatment group revealed 162 genes that were commonly 
induced or repressed by both agonists, 65 transcripts uniquely 
altered by TCDD treatment, and 235 genes that responded 
only to FICZ exposure.
Figure 2. Relative gene expression of CYP1A6. Treatment 
with TCDD resulted in a 76.06 fold change induction of 
CYP1A6, while FICZ treatment resulted in a fold change of 
119.7 (n=3, one-way ANOVA p=0.0464).	Error	bars	=	SEM.
Treatment of Cells: Xenopus laevis kidney cells (XLK-WG) were treated 
with 175 nM TCDD or 0.2 nM FICZ, concentrations corresponding to the 
EC50 for CYP1A6 induction.
RNA Extraction: Total RNA was extracted from the cells using RNEasy 
RNA Extraction kit (Qiagen) for use in RNAseq analysis to determine gene 
expression.
Sequencing & Assembly: Sequencing was performed by Cofactor 
Genomics through the Illumina platform. Sequences were analyzed using 
Trinity de novo transcript assembly and Tuxedo mapping to Xenopus 
laevis genome 7.0 (Neel Aluru, WHOI).
Chemical structure of exogenous 
AHR agonist 2,3,7,8 
tetrachlorodibenzo-p-dioxin 
(TCDD) 
[https://upload.wikimedia.org/wikipedia/
commons/8/84/2,3,7,8-TCDD-2D-skeletal.png]
Chemical structure of endogenous 
AHR agonist 6-formylindolo (3,2-b) 
carbazole (FICZ)
 [http://www.stressmarq.com/wp-content/
uploads/SIH-383_6-Formylindolo3-2-
bcarbazole_Chemical_Structure.png]
cDNA synthesis: RNA extracted from treated cells was reverse 
transcribed using the TaqMan Reverse Transcription kit (Applied 
Biosystems).
qPCR: cDNA was amplified using Power SYBR Green Master Mix 
(Applied Biosystems). To find the fold change induction or 
repression of target genes, the ΔΔCt value was calculated and data 
was normalized to a DMSO control group.
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RNAseq	Analysis	
[h2p://www.nature.com/nbt/journal/v28/n5/images_arFcle/nbt0510-421-F1.gif]	
Figure 3. Relative gene expression of AHR targets. Treatment 
with TCDD resulted in induced gene expression in SYNE1 
(p=0.0071), GJC1 (p=0.0464), and TIPARP1.L (p=0.0464), 
approximately no change in NDUFC1.S (p=0.8197) and repressed 
gene expression in NOV.L (p=0.3000). FICZ treatment resulted 
identical trends in gene expression despite RNAseq predictions of 
agonist-dependent gene expression (for all samples, n=3, p-values 
represent one-way ANOVA). Error bars=SEM.
•  Genes marked in RNAseq as commonly induced in both 
TCDD and FICZ treatment groups held their gene 
expression trends in qPCR analysis. CYP1A6, SYNE1, and 
GJC1 all showed an increase in gene exxpression when treated 
with either TCDD or FICZ
•  Agonist-dependent AHR gene targets identified in RNAseq 
data showed non-unique gene expression trends in qPCR 
analysis. TIPARP.L, identified as a gene induced exclusively in 
TCDD treatment groups, showed increased expression in both 
TCDD and FICZ treatment groups in qPCR analysis. Similarly, 
RNAseq data identified NOV.L as a gene repressed exclusively 
in TCDD treatment groups. However, qPCR identified that this 
repression was present in both treatment groups. NDUFC1.S, 
suspected to be repressed under FICZ treatment in RNAseq 
data, showed an insignificant change in gene expression in both 
treatment groups
•  Selective modulation may not be a potential explanation for 
toxicity in cells. Further research can reveal the cause for 
discrepancies in RNAseq and qPCR data.
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